SCHEMBL30356302

SCHEMBL30356302

CN(C)c1ccccc1NC(N)=S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
GAA P10253 4/20 0.47
MAPT P10636 4/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.46
TP53 P04637 2/20 0.45
TSHR P16473 2/20 0.45
TYR P14679 1/20 0.45
TAS2R38 P59533 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX12 P18054 1/20 0.43
CYP2C19 P33261 1/20 0.43
KCNQ2 O43526 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814232 1.00 L3MBTL1 (0.53) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL11166274 0.86 L3MBTL1 (0.47) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL11704484 0.84 KCNQ2 (0.44) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL5898502 0.84 MAPT (0.47) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL2942491 0.82 KCNQ2 (0.50) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL30356288 0.80 L3MBTL1 (0.49) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL7500203 0.79 GAA (0.54) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL7593748 0.79 L3MBTL1 (0.71) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL30356289 0.77 KMT2A (0.43) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL9576991 0.75 L3MBTL1 (0.47) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250186309-A1 DENTAL CURABLE COMPOSITION AND DENTAL KIT KURARAY NORITAKE DENTAL INC. (JP) 2025-06-12 US disclosed
EP-4413968-A1 CURABLE DENTAL COMPOSITION AND DENTAL KIT Kuraray Noritake Dental Inc. (JP) 2024-08-14 EP disclosed
CN-115894884-B Trifunctional organic catalyst and preparation method and application thereof 浙江大学 2024-07-05 CN disclosed
WO-2023058773-A1 CURABLE DENTAL COMPOSITION AND DENTAL KIT クラレノリタケデンタル株式会社 2023-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250186309-A1 DENTAL CURABLE COMPOSITION AND DENTAL KIT KIT, DNMT3L, CDK6 L3MBTL1 2739/4885ALDH1A1 2887/4885SMN1; SMN2 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.